The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques - Role of glycemic control

被引:330
作者
Cipollone, F
Iezzi, A
Fazia, M
Zucchelli, M
Pini, B
Cuccurullo, C
De Cesare, D
De Blasis, G
Muraro, R
Bei, R
Chiarelli, F
Schmidt, AM
Cuccurullo, F
Mezzetti, A
机构
[1] Univ Chieti G DAnnunzio, Sch Med, Chieti, Italy
[2] S Filippo & Nicola Hosp, Avezzano, Italy
[3] Univ Roma Tor Vergata, Sch Med, Rome, Italy
[4] Columbia Univ, New York, NY USA
关键词
diabetes mellitus; plaque; inflammation; prostaglandins; metalloproteinases;
D O I
10.1161/01.CIR.0000086014.80477.0D
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-RAGE (receptor for advanced glycation end products [AGEs]) plays a role in diabetic atherosclerosis. Recently, we have demonstrated enhanced expression of cyclooxygenase-2 and PGE synthase-1 (COX-2/mPGES-1) in human symptomatic plaques, and provided evidence that it is associated with metalloproteinase (MMP)-induced plaque rupture. However, the specific transmembrane signaling pathway(s) influencing plaque COX-2/mPGES-1 expression is unknown. The aim of this study was to characterize RAGE expression in human plaques and to correlate it with the inflammatory infiltration, COX-2/mPGES-1 and MMP expression, and with clinical evidence of diabetes. Methods and Results-Plaques obtained from 60 patients undergoing carotid endarterectomy were divided into diabetic and nondiabetic according to clinical evidence of type 2 diabetes. Plaques were subjected to analysis of RAGE, NF-kappaB, COX-2/mPGES-1, MMP-2 and MMP-9, lipid and oxidized LDL (oxLDL) content, and collagen content by immunohistochemistry and Western blot, whereas zymography was used to detect MMP activity. Immunohistochemistry was used to identify CD68+ macrophages, CD3+ T-lymphocytes, smooth muscle cells (SMCs), and HLA-DR+ inflammatory cells. Diabetic plaques had more (P<0.0001) macrophages, T-lymphocytes, and HLA-DR+ cells, more (P<0.0001) immunoreactivity for RAGE, activated NF-kappaB, COX-2/mPGES-1, and MMPs, increased (P<0.0001) gelatinolytic activity, reduced (P<0.0001) collagen content, and increased (P<0.0001) lipid and oxLDL content. Interestingly, RAGE, COX-2/mPGES-1, and MMP expression was linearly correlated with plasma level of HbA1c. Conclusions-In conclusion, this study demonstrates in humans that RAGE overexpression is associated with enhanced inflammatory reaction and COX-2/mPGES-1 expression in diabetic plaque macrophages, and this effect may contribute to plaque destabilization by inducing culprit metalloproteinase expression.
引用
收藏
页码:1070 / 1077
页数:8
相关论文
共 18 条
[1]   Advanced glycation end products activate endothelium through signal-transduction receptor RAGE - A mechanism for amplification of inflammatory responses [J].
Basta, G ;
Lazzerini, G ;
Massaro, M ;
Simoncini, T ;
Tanganelli, P ;
Fu, CF ;
Kislinger, T ;
Stern, DM ;
Schmidt, AM ;
De Caterina, R .
CIRCULATION, 2002, 105 (07) :816-822
[2]   Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion [J].
Brand, K ;
Page, S ;
Rogler, G ;
Bartsch, A ;
Brandl, R ;
Knuechel, R ;
Page, M ;
Kaltschmidt, C ;
Baeuerle, PA ;
Neumeier, D .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (07) :1715-1722
[3]   RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice [J].
Bucciarelli, LG ;
Wendt, T ;
Qu, W ;
Lu, Y ;
Lalla, E ;
Rong, LL ;
Goova, MT ;
Moser, B ;
Kislinger, T ;
Lee, DC ;
Kashyap, Y ;
Stern, DM ;
Schmidt, AM .
CIRCULATION, 2002, 106 (22) :2827-2835
[4]   Suppression of the functionally coupled cyclooxygenase-2/prostaglandin E synthase as a basis of simvastatin-dependent plaque stabilization in humans [J].
Cipollone, F ;
Fazia, M ;
Iezzi, A ;
Zucchelli, M ;
Pini, B ;
De Cesare, D ;
Ucchino, S ;
Spigonardo, F ;
Bajocchi, G ;
Bei, R ;
Muraro, R ;
Artese, L ;
Piattelli, A ;
Chiarelli, F ;
Cuccurullo, F ;
Mezzetti, A .
CIRCULATION, 2003, 107 (11) :1479-1485
[5]   Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E2-dependent plaque instability [J].
Cipollone, F ;
Prontera, C ;
Pini, B ;
Marini, M ;
Fazia, M ;
De Cesare, D ;
Iezzi, A ;
Ucchino, S ;
Boccoli, G ;
Saba, V ;
Chiarelli, F ;
Cuccurullo, F ;
Mezzetti, A .
CIRCULATION, 2001, 104 (08) :921-927
[6]   Specific interaction of oxidized low-density lipoprotein with macrophage-derived foam cells isolated from rabbit atherosclerotic lesions [J].
de Vries, HE ;
Buchner, B ;
van Berkel, TJC ;
Kuiper, J .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (03) :638-645
[7]   INCREASED EXPRESSION OF MATRIX METALLOPROTEINASES AND MATRIX-DEGRADING ACTIVITY IN VULNERABLE REGIONS OF HUMAN ATHEROSCLEROTIC PLAQUES [J].
GALIS, ZS ;
SUKHOVA, GK ;
LARK, MW ;
LIBBY, P .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (06) :2493-2503
[8]   Global burden of diabetes, 1995-2025 - Prevalence, numerical estimates, and projections [J].
King, H ;
Aubert, RE ;
Herman, WH .
DIABETES CARE, 1998, 21 (09) :1414-1431
[9]   Nε-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression [J].
Kislinger, T ;
Fu, CF ;
Huber, B ;
Qu, W ;
Taguchi, A ;
Yan, SD ;
Hofmann, M ;
Yan, SF ;
Pischetsrieder, M ;
Stern, D ;
Schmidt, AM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (44) :31740-31749
[10]   Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice [J].
Kislinger, T ;
Tanji, N ;
Wendt, T ;
Qu, W ;
Lu, Y ;
Ferran, LJ ;
Taguchi, A ;
Olson, K ;
Bucciarelli, L ;
Goova, M ;
Hofmann, MA ;
Cataldegirmen, G ;
D'Agati, V ;
Pischetsrieder, M ;
Stern, DM ;
Schmidt, AM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (06) :905-910